Article Menu
Need Help?
No Article Versions Notes Found
Cite
Lachance, S.; Christofides, A.L.; Lee, J.K.; Sehn, L.H.; Ritchie, B.C.; Shustik, C.; Stewart, D.A.; Toze, C.L.; Haddad, E.; Vinh, D.C. A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia. Curr. Oncol. 2016, 23, 42-51. https://doi.org/10.3747/co.23.2810
Lachance S, Christofides AL, Lee JK, Sehn LH, Ritchie BC, Shustik C, Stewart DA, Toze CL, Haddad E, Vinh DC. A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia. Current Oncology. 2016; 23(1):42-51. https://doi.org/10.3747/co.23.2810
Chicago/Turabian StyleLachance, S., A.L. Christofides, J.K. Lee, L.H. Sehn, B.C. Ritchie, C. Shustik, D.A. Stewart, C.L. Toze, E. Haddad, and D.C. Vinh. 2016. "A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia" Current Oncology 23, no. 1: 42-51. https://doi.org/10.3747/co.23.2810
APA StyleLachance, S., Christofides, A. L., Lee, J. K., Sehn, L. H., Ritchie, B. C., Shustik, C., Stewart, D. A., Toze, C. L., Haddad, E., & Vinh, D. C. (2016). A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia. Current Oncology, 23(1), 42-51. https://doi.org/10.3747/co.23.2810
